Nutrition and Diabetes
A section of Nutrients (ISSN 2072-6643).
Section Information
Over the last few decades, diabetes incidence has grown from around 3.5% of the adult population in Europe to around 10%. The underlying fat storage (adiposity) has become the most prevalent metabolic disorder worldwide. Taken both together with hyperlipidemia and hypertension, they are the major risk factors for cardiovascular disease, non-alcoholic fatty liver disease, cancer, and numerous other complications. In the last few years, our knowledge of diabetes and adiposity, often called “diabesity”, has greatly improved, but more research is needed to better understand the mechanisms underlying the development of this metabolic condition and its diagnosis and pathophysiology, as well as to optimize its management.
We welcome original research articles describing basic, clinical, and applied studies representing novel and significant advances in all areas relevant to Type 1 and Type 2 diabetes and related disorders, as well as reviews. The areas of research covered by this Section relate to all aspects of diabetes diagnosis, pathophysiology, and treatment.
Topics include, but are not limited to:
- Type 2 diabetes and diabesity;
- Diabetes phenotyping;
- Body composition;
- Energy expenditure;
- Adipose tissue pathophysiology;
- Adipokines;
- Omic studies;
- Genetics;
- Biomarkers;
- Lifestyle intervention;
- Physical activity;
- Nutrition in Type 1 diabetes, including psychosocial factors;
- Nutrition in Type 2 diabetes, including psychosocial factors;
- Nutritional epidemiology;
- Regulation of appetite;
- Behavior therapy in appetite regulation;
- Pediatric Type 1 diabetes, diabesity, and Type 2 diabetes;
- Metabolic syndrome;
- Cardiometabolic risk factors;
- Aging;
- Non-alcoholic fatty liver disease;
- Animal models;
- Dietary treatment;
- Pharmacological treatment;
- Metabolic surgery in prevention and treatment of Type 2 diabetes;
- Effects and limitations of various fasting procedures;
- Cardiometabolic risk following weight loss and weight (re)gain;
- Body composition changes;
- Predictors of treatment success;
- Use of apps for nutrition management;
- Novel targets;
- Transgenerational effects;
- Controversies in diabetes.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Effect of Dietary Natural Products on Diabetes and Its Complications (Deadline: 5 May 2024)
- The Effect of Dietary Interventions on Obesity and Type 2 Diabetes in the Era of the Incretin-Based Therapies (Deadline: 5 May 2024)
- Impact of Diet Composition on Insulin Resistance—Second Edition (Deadline: 25 June 2024)
- Diabetes: Diet and Health Conditions (Deadline: 25 June 2024)
- Impact of Nutritional Regulation on the Control of Glucose Homeostasis and Type 2 Diabetes Mellitus (Deadline: 5 July 2024)
- A New Perspective on Mediterranean Diet and Type 2 Diabetes (Deadline: 15 July 2024)
- Current and New Approaches to Managing Diabetes through Diet (Deadline: 15 July 2024)
- The Impact of Vegan Diet in the Prevention and Treatment of Type 2 Diabetes (Deadline: 5 August 2024)
- Nutrients as Risk Factors and Treatments for Gestational Diabetes (Deadline: 15 August 2024)
- Dietary Interventions for Patients with Type 2 Diabetes (Deadline: 25 August 2024)
- The Influence of Nutrition and Diet Management on the Origin of Type 2 Diabetes (Deadline: 25 August 2024)
- Nutrition and Lifestyle Intervention in Type 1 Diabetes (Deadline: 5 September 2024)
- Update on Diet, Nutrition and Type 2 Diabetes: Separating the Science from the Hype (Deadline: 5 September 2024)
- Diet Quality, Cardiometabolic Risk and Diabetes (Deadline: 5 September 2024)
- Nutritional and Dietary Approaches to Diabetes (Deadline: 25 October 2024)
- Nutritional and Dietary Approaches in Type 1 Diabetes (Deadline: 25 October 2024)
- Dietary and Behavioral Interventions for Diabetes (Deadline: 25 October 2024)
- Nutrition, Physical Activity and Alternative Therapies in Diabetes and Obesity (Deadline: 25 October 2024)
- Diabetes Mellitus and Nutritional Supplements (Deadline: 30 October 2024)